Sandra Bak Mueller

Inhibition of Sphingomyelin Synthesis Reduces Atherogenesis in Apolipoprotein E–Knockout Mice

Tae‐Sik Park, Robert L. Panek, Sandra Bak Mueller et al. · Circulation · 2004 · 222 citations · Full text

Life Sciences, Biochemistry, Pharmacology +17

Comparison of CI-976, an ACAT inhibitor, and selected lipid-lowering agents for antiatherosclerotic activity in iliac-femoral and thoracic aortic lesions. A biochemical, morphological, and morphometric evaluation.

Thomas Bocan, Sandra Bak Mueller, Paul D. Uhlendorf et al. · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · 1991 · 157 citations

Pharmacy, Pharmacology, Pharmacotherapy +17

A specific 15-lipoxygenase inhibitor limits the progression and monocyte–macrophage enrichment of hypercholesterolemia-induced atherosclerosis in the rabbit

Thomas Bocan, Wendy S. Rosebury, Sandra Bak Mueller et al. · Atherosclerosis · 1998 · 117 citations

Life Sciences, Pathobiology, Pharmacology +14

The relationship between the degree of dietary-induced hypercholesterolemia in the rabbit and atherosclerotic lesion formation

Thomas Bocan, Sandra Bak Mueller, Paul D. Uhlendorf et al. · Atherosclerosis · 1993 · 114 citations

Life Sciences, Cardiology, Nutritional Sciences +12

The ACAT Inhibitor Avasimibe Reduces Macrophages and Matrix Metalloproteinase Expression in Atherosclerotic Lesions of Hypercholesterolemic Rabbits

Thomas Bocan, Brian R. Krause, Wendy S. Rosebury et al. · Arteriosclerosis Thrombosis and Vascular Biology · 2000 · 113 citations · Full text

Life Sciences, Cardiology, Pharmacology +17